Lederer & Associates Investment Counsel’s AbbVie ABBV Stock Holding History

Lederer & Associates Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.66M	Sell	10,585 -223	-2%	-$48K	1.75%	13
2026 Q1	$2.35M	Buy	10,808 +53	+0.5%	+$11.8K	1.67%	18
2025 Q4	$2.46M	Sell	10,755 -212	-2%	-$48.3K	1.65%	14
2025 Q3	$2.54M	Sell	10,967 -37	-0.3%	-$7.54K	1.65%	13
2025 Q2	$2.04M	Buy	11,004 +134	+1%	+$24.9K	1.35%	21
2025 Q1	$2.28M	Buy	10,870 +549	+5%	+$107K	1.67%	16
2024 Q4	$1.83M	Buy	+10,321	New	+$1.9M	1.28%	22
2019 Q2	–	Sell	-14,045	Closed	-$1.13M	–	89
2019 Q1	$1.13M	Buy	14,045 +7,470	+114%	+$611K	1.05%	46
2018 Q4	$606K	Sell	6,575 -6,220	-49%	-$547K	0.65%	50
2018 Q3	$1.21M	Buy	12,795 +485	+4%	+$46K	1.02%	49
2018 Q2	$1.14M	Sell	12,310 -15	-0.1%	-$1.47K	1.03%	48
2018 Q1	$1.17M	Buy	+12,325	New	+$1.35M	1.05%	47

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lederer & Associates Investment Counsel's ABBV Position: Q2 2026 in Review

Lederer & Associates Investment Counsel reduced its AbbVie (ABBV) stake by 2.1% in Q2 2026, selling an estimated $48K and leaving 10,585 shares worth $2.66M. The position accounts for 1.75% of the portfolio, ranked #13.

Lederer & Associates Investment Counsel first reported a position in ABBV in Q1 2018 and has held it in 12 quarters since. 1,934 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Lederer & Associates Investment Counsel held 10,585 shares of AbbVie worth $2.66M as of Q2 2026.
Lederer & Associates Investment Counsel sold 223 AbbVie shares in Q2 2026, an estimated $48K.
AbbVie made up 1.75% of Lederer & Associates Investment Counsel's portfolio in Q2 2026, its #13 holding.
Lederer & Associates Investment Counsel first reported a position in AbbVie in Q1 2018 and has held it in 12 quarters since.
1,934 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lederer & Associates Investment Counsel's 13F filing for Q2 2026, filed 10 Jul 2026.